Integer (NYSE:ITGR) Lowered to Hold Rating by Argus

Key Points

• Integer Holdings was downgraded by Argus from a "buy" to a "hold" rating, reflecting a change in market perception after recent earnings.
• Various analysts have revised their price targets for Integer, with estimates ranging from $82.00 to $133.00, while the average price target stands at $97.75.
• In its latest earnings report, Integer outperformed expectations with earnings per share of $1.79, exceeding the consensus estimate by $0.11.

Integer (NYSE:ITGR - Get Free Report) was downgraded by research analysts at Argus from a "buy" rating to a "hold" rating in a research note issued on Friday, MarketBeat reports.

Other analysts also recently issued reports about the stock. Benchmark reissued a "hold" rating on shares of Integer in a research note on Friday. Truist Financial lowered their price target on shares of Integer from $121.00 to $88.00 and set a "buy" rating for the company in a research note on Friday. KeyCorp lowered their price target on shares of Integer from $145.00 to $133.00 and set an "overweight" rating for the company in a research note on Tuesday. Piper Sandler lowered their price target on shares of Integer from $155.00 to $82.00 and set an "overweight" rating for the company in a research note on Friday. Finally, Raymond James Financial reissued an "outperform" rating and issued a $95.00 price target (down from $143.00) on shares of Integer in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat, Integer currently has an average rating of "Hold" and an average price target of $97.75.

Integer Price Performance

Shares of NYSE ITGR traded down $0.95 during mid-day trading on Friday, reaching $72.94. 3,695,077 shares of the company were exchanged, compared to its average volume of 546,573. Integer has a 52 week low of $66.50 and a 52 week high of $146.36. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $2.56 billion, a PE ratio of 32.13, a PEG ratio of 0.86 and a beta of 0.97. The company's 50 day moving average price is $104.29 and its 200 day moving average price is $112.67.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.68 by $0.11. The company had revenue of $467.69 million during the quarter, compared to the consensus estimate of $466.45 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm's revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Sell-side analysts forecast that Integer will post 6.01 earnings per share for the current fiscal year.

Institutional Trading of Integer

A number of institutional investors have recently modified their holdings of the company. TD Private Client Wealth LLC boosted its holdings in shares of Integer by 5.8% during the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after purchasing an additional 83 shares during the period. CWM LLC boosted its holdings in shares of Integer by 46.1% during the second quarter. CWM LLC now owns 355 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 112 shares during the period. Xponance Inc. boosted its holdings in shares of Integer by 5.1% during the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after purchasing an additional 122 shares during the period. Bessemer Group Inc. boosted its holdings in shares of Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider's stock worth $98,000 after purchasing an additional 134 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.